SERPINB3 and cholangiocarcinoma: Fifteen tumors (12.2%) were positive for high levels of SerpinB3/4 (score 2+/3+), and 108 patients (87.8%) had low levels (score of 0/1+) of SerpinB3/4 within the CCA cells.